🟢 Indaptus Therapeutics is trading 9.24% up in pre-market

Indaptus Therapeutics is trading at $2.60, up 9.24% in pre-market, with no clear catalyst identified.

• No verified October 5 company announcement was found; the latest identified company-specific news is older and does not explain the move.
• Supplied market indicators are mixed, with no broad same-direction move large enough to explain the gain. Recent stock volatility adds context but does not establish a cause.
• Pre-market volume was not provided, so trading activity level cannot be assessed.